Literature DB >> 15771936

Sibutramine: possible cause of a reversible cardiomyopathy.

Tamer Sayin, Muharrem Güldal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15771936     DOI： 10.1016/j.ijcard.2003.11.060

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN： 0167-5273            Impact factor:   4.164


× No keyword cloud information.
  3 in total

Review 1.  Safety of drug therapies used for weight loss and treatment of obesity.

Authors:  Lisa L Ioannides-Demos; Joseph Proietto; Andrew M Tonkin; John J McNeil
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Anti-obesity effect of an isoflavone fatty acid ester on obese mice induced by high fat diet and its potential mechanism.

Authors:  Yao Yao; Xiao-Bo Li; Wei Zhao; Yan-Yan Zeng; Hong Shen; Hua Xiang; Hong Xiao
Journal:  Lipids Health Dis       Date:  2010-05-19       Impact factor: 3.876

3.  A case of dilated cardiomyopathy with massive left ventricular thrombus after use of a sibutramine-containing slimming product.

Authors:  Seung Hye Heo; Min-Ho Kang
Journal:  Korean Circ J       Date:  2013-09-30       Impact factor: 3.243
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.